-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Relmada Therapeutics, Inc. annual/quarterly Return On Equity history and growth rate from Q2 2022 to Q3 2022.
- Relmada Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2022 was -78.5 %.
- Relmada Therapeutics, Inc. annual Return On Equity for 2023 was -93.4 %, a 6.22% decline from 2022.
- Relmada Therapeutics, Inc. annual Return On Equity for 2022 was -88 %, a 18% increase from 2021.
- Relmada Therapeutics, Inc. annual Return On Equity for 2021 was -107 %, a 113% decline from 2020.
Return On Equity, Quarterly (%)